Summary: Medscape highlights MAPS’ recent announcement of a successful confirmatory Phase 3 trial of MDMA-assisted therapy for posttraumatic stress disorder (PTSD).
“A new study provides strong supportive evidence that adding MDMA to [therapy] can significantly improve symptoms and well-being for patients with severe posttraumatic stress disorder (PTSD),” writes Medscape.
Medscape: More Support for MDMA-Assisted Psychotherapy for PTSD
